KEGG analysis showed that miRNA targets are involved in several cancer-related pathways, including small cell lung cancer, prostate cancer, pancreatic cancer, chronic myeloid leukemia, breast cancer, p53 signaling pathway, PI3K-Akt signaling pathway, etc (Figure 6). This evidence concerns the gene TP53 and pancreatic neoplasm.